STOCK TITAN
  1. Home
  2. Sec-filings
  3. VNRX
  4. [EFFECT] VolitionRX Limited SEC Filing

[EFFECT] VolitionRX Limited SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 14, 2025 5:00 P.M.
Form: S-3
CIK: 0000093314
Company Name: VOLITIONRX LTD
File Number: 333-288508

Source: View Original Filing on SEC EDGAR

Volitionrx

NYSE:VNRX

View VNRX Stock Overview →

VNRX Rankings

#6007 Ranked by Market Cap
N/A Ranked by Dividends
#272 Top Gainer

VNRX Latest News

Mar 18, 2026
Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA
Mar 6, 2026
Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems
Feb 25, 2026
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution
Feb 10, 2026
Volition Announces the Appointment of New Distributor for Nu.Q® Discover
Feb 9, 2026
VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

VNRX Latest SEC Filings

Mar 19, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity
Mar 19, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity
Mar 19, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity
Mar 19, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity
Mar 3, 2026
[Form 4] VOLITIONRX LTD Insider Trading Activity

VNRX Stock Data

25.76M
113.05M
Medical Devices
In Vitro & in Vivo Diagnostic Substances
Link
United States
HENDERSON